It was recently shown that metformin blocks NLRP3 inflammasome activation including inhibition of IL-1β and IL-6 in alveolar macrophages attenuating SARS-CoV-2-induced ARDS in a mouse model.93 This evidence concerns the gene IL6 and acute respiratory distress syndrome.